Absci is a biotechnology company that specializes in the development of protein-based therapeutics using its proprietary deep learning and synthetic biology platform. The company focuses on optimizing the discovery and production of complex biologics, including antibodies and other proteins, to enhance drug development processes. Absci aims to accelerate the creation of innovative treatments for various diseases by integrating advanced technology with biological research.